Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MRNA · against 557 other Healthcare companies listed in US-listed
Ranked #401 of 558 · scores higher than 26% of peers
Bars: peers in each 10-point band of the profitability score114 peers with a profitability score of 10–19, including MRNA · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | MRNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -46.6% | -7.0% | 26% | 33% | |
| Operating marginHigher is better · 479 reported | -149.0% | -2.4% | 23% | 33% | |
| Return on assetsHigher is better · 582 reported | -28.7% | -7.8% | 30% | 33% | |
| Return on equityHigher is better · 531 reported | -39.0% | -19.7% | 38% | Context only | |
| Gross marginHigher is better · 601 reported | -66.0% | 43.9% | 4% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 401 | 2.7B USD | 14 | 50 | |
| 401 | 23.5B USD | 14 | 27 | |
| 401 | 22.8B USD | 14 | 38 | |
| 401 | 1.7B USD | 14 | 46 | |
| 401 | 91.2B USD | 14 | 18 | |
| 401 | 170M USD | 14 | 35 | |
| 401 | 41.6B USD | 14 | 34 | |
| 401 | 2.0B USD | 14 | 26 | |
| 401 | 684M USD | 14 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score